ROCKVILLE, Md., Apr 20, 2012 (BUSINESS WIRE) --Human Genome Sciences, Inc. (NASDAQ: HGSI) announced today that it will
sponsor a conference call to discuss its financial results for the
quarter ended March 31, 2012. These results are expected to be disclosed
on Tuesday, April 24, 2012, after the capital markets close.
The conference call will be hosted by senior management and will be held
on Tuesday, April 24, 2012 at 4:30 pm Eastern Time.
Investors may listen to the call by dialing 888-312-9844 or
719-325-2111, passcode 3946943. A replay of the conference call will be
available within a few hours after the call ends. Investors may listen
to the replay by dialing 888-203-1112 or 719-457-0820, confirmation code
This conference call also will be webcast and can be accessed at www.hgsi.com.
It is recommended that investors interested in listening to the live
webcast log on before the start of the call to download any software
required. Both the audio replay and the archive of the conference call
webcast will remain available for several days.
ABOUT HUMAN GENOME SCIENCES
Human Genome Sciences exists to place new therapies into the hands of
those battling serious disease.
For more information about HGS, please visit the Company's web site at www.hgsi.com.
Health professionals and patients interested in clinical trials of HGS
products may inquire via e-mail to firstname.lastname@example.org
or by calling HGS at (240) 314-4430.
HGS and Human Genome Sciences are trademarks of Human Genome Sciences,
Inc. Other trademarks referenced are the property of their respective
SOURCE: Human Genome Sciences, Inc.
Human Genome Sciences, Inc.
Director, Corporate Public Relations
Vice President, Corporate Communications
Claudine Prowse, Ph.D.
Vice President, Investor